The Heldrich Hotel and Conference Center
10 Livingston Ave
New Brunswick, NJ 08901
Jointly provided by Rutgers Robert Wood Johnson Medical School and RWJ Barnabas Health
It has been well established that cardiovascular disease (CVD) is the number one killer of individuals in the United States. Despite maximal efforts in prevention and treatment, this number continues to grow year after year. As a consequence, we are treating more and more heart failure (often the end result of chronic CVD) with optimal medical therapy as well as devices to support the failing heart, with as many as 670,000 new cases being diagnosed each and every year. Despite our ever-evolving research and technology into the treatment of this ever-growing patient population, the mortality rate remains high with 50% of patients diagnosed with heart failure dying within 5 years of diagnosis.
Treatment for all patients with cardiovascular disease is becoming more and more complex with emerging technologies treating a sicker and more complex patient population. As these treatment strategies continue to change with advancing research and technology, we need to involve multiple specialties employing a true multidisciplinary approach to treating these patients often with end stage disease and resultant heart failure. The goal of this conference is to expose cardiovascular healthcare practitioners to the multitude of disease entities encompassing cardiovascular diseases and demonstrate current and novel treatments elucidated through case presentations and panel discussions.
To view the full conference agenda, click here
This activity is designed for cardiologists, cardiothoracic surgeons, internists, residents, fellows, physician assistants, nurse practitioners, cardiac nurses, cardiovascular technologists, cardiovascular program administrators and researchers.
Upon completion of this activity, participants should be better able to:
- Develop individualized treatment strategies for patients who require mechanical circulatory support
- Identify key assessment criteria to determine the appropriate use of VA ECMO in patients with heart failure
- Apply the latest guideline recommendations for the post-PCI management of patients who require antiplatelet therapy
- Compare the differences between and difficulties of surgical and minimally invasive approaches to mitral valve replacement or repair
- Define specific components of modern cardiovascular medicine where redesign can have the largest impact
- State the risks and outcomes of percutaneous left atrial appendage closure to prevent cryptogenic stroke in patients who are not candidates for long-term anticoagulation
- Describe the benefits of the multidisciplinary approach to the early detection and prevention of PVD complications
James Coromilas, MD
Professor of Medicine and Director, Division of Cardiovascular Disease and Hypertension, Rutgers Robert Wood Johnson Medical School, Robert Wood Johnson University Hospital
Leonard Y. Lee, MD
Professor of Surgery, James W. Mackenzie, MD Endowed Chair in Surgery, Senior Associate Dean for Clinical Affairs, Interim Chair, Department of Surgery, Rutgers Robert Wood Johnson Medical School; Vice President for Clinical Affairs, Rutgers Health Group
Abel E. Moreyra, MD
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Stephern Allison, DHSc, MBA, MSM, MPAS, PA
Vice President of Operations – Cardiovascular Services & Care Management/Social Work, Robert Wood Johnson University Hospital
James Andrews, MHL
System Vice President, Cardiac Services, RWJBarnabas Health
Michael Cargill, BSN, RN
Cath Lab/EP Staff Nurse, Robert Wood Johnson University Hospital
Robert K. Altman, MD
Cardiac Electrophysiologist, Summit Medical Group
Anthony Altobelli, III, MD
Cardiologist (Non-Invasive), RWJPE Cardiology Associates of New Brunswick
Ashish Awasthi, MD
Interventional Cardiologist, RWJPE Heart Specialists of Central Jersey; Co-Director, Endovascular Program, Robert Wood Johnson University Hospital
George Batsides, MD
Associate Professor of Surgery, Chief, Section of Cardiac Surgery, Surgical Director, Mechanical Circulatory Support, Rutgers Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital
Billie Bellamy, MSN, RN
Clinical Director, Surgical Intensive Care Unit East, Open Heart Recovery Room, Head/Staff Nurse, Robert Wood Johnson University Hospital
Bruce J. Brener, MD
Director, Vascular Center of Barnabas Health; Director of Vascular Surgery, Fellowship Program Director, Medical Director, Vascular Lab, Newark Beth Israel Medical Center
Marc Cohen, MD
Professor of Medicine, Director, Cardiology Fellowship Training Program, Rutgers New Jersey Medical School; Chief, Division of Cardiology, Newark Beth Israel Medical Center
David P. Dobesh, MD
Cardiac Electrophysiologist, New Jersey Cardiology Associates
Matthew Emerick, BSN, RN
Assistant Director, Cardiac Critical Care, Robert Wood Johnson University Hospital
Subhashini Gowda, MD
Director of Arrhythmia Services, RWJPE New Brunswick Cardiology Group
Bruce J. Haik, MD
RWJBarnabas Health System Director of Cardiac Catheterization Laboratories
Jason O. Hall, MD
Chief, Division of Cardiology. Robert Wood Johnson University Hospital - Somerset
Steven M. Hertz, MD, RVT
Chief, Vascular Surgery, Saint Barnabas Medical Center
Calum A. MacRae, MD, PhD
Chief, Cardiovascular Division, Co-Chair, Genomic Medicine Program, Brigham and Women's Hospital; Associate Professor, Harvard Medical School
Kataneh Maleki, MD
Cardiac Electrophysiologist, Robert Wood Johnson University Hospital
Kanika P. Mody, MD
Assistant Professor of Medicine, Rutgers Robert Wood Johnson Medical School; Advanced Heart Failure, VAD and Transplant Cardiologist, Medical Director, Coronary Care Unit, Robert Wood Johnson University Hospital
Khanjan H. Nagarsheth, MD
Assistant Professor of Surgery, Division of Vascular Surgery and Endovascular Therapy, Rutgers Robert Wood Johnson Medical School
Casey G. Panebianco, DNP, RN, APN
Lead APN, Cardiac Surgery APN/PA Service, Robert Wood Johnson University Hospital
Saum A. Rahimi, MD, FACS
Assistant Professor of Surgery, Norman and Ruth H. Rosenberg Chair in Vascular Surgery, Chief, Division of Vascular Surgery and Endovascular Therapy, Rutgers Robert Wood Johnson Medical School
Marc Roelke, MD
Director of Electrophysiology, Newark Beth Israel Medical Center and Saint Barnabas Medical Center
Gary J. Rogal, MD
Chief of Cardiology, RWJ Barnabas Health
Mark Russo, MD, MS
Assistant Professor of Surgery, Rutgers New Jersey Medical School; Director, Structural Heart Disease, Director, Center for Aortic Diseases, Director, Cardiac Surgery Research, Newark Beth Israel Medical Center and Saint Barnabas Medical Center
Amardeep (Deepak) Saluja, MD
Assistant Professor of Medicine, Rutgers Robert Wood Johnson Medical School; Director, Clinical Cardiac Electrophysiology Lab, Robert Wood Johnson University Hospital
Craig R. Saunders, MD
Chairman of Cardiothoracic Surgery, RWJ Barnabas Health
Martin Strueber, MD
Director, Cardiothoracic Transplant Surgery and Mechanical Circulatory Support, Department of Cardiothoracic Surgery, Newark Beth Israel Medical Center
Hiroo Takayama, MD, PhD
Associate Professor of Surgery, Director of Cardiovascular Institute; Co-Director, Aortic Program; Co-Director, Marfan Clinic; Co-Director, HCM Program, Division of Cardiac, Vascular & Thoracic Surgery, Columbia University Medical Center
Tudor D. Vagaonescu, MD, PhD
Associate Professor of Medicine, Rutgers Robert Wood Johnson Medical School; Medical Director, Cardiac Catheterization Laboratories, Robert Wood Johnson University Hospital
Zyad Younan, MD
Cardiac Electrophysiologist, Robert Wood Johnson University Hospital
Mark J. Zucker, MD, JD
Director, Heart Failure Treatment and Transplant Program, Newark Beth Israel Medical Center
All individuals who affect the content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/ investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.
CONTINUING EDUCATION CREDIT
||In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and RWJ Barnabas Health. Rutgers Biomedical and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is awarded 5 contact hours. (60 minute CH) Nurses should only claim those contact hours actually spent participating in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 5 Category 1 credits for completing this activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
METHOD OF PARTICIPATION
In order to meet the learning objectives and receive continuing education credit for this activity, participants are required to check in at the registration desk, attend the activity, and complete the online evaluation form at the conclusion of the activity. A letter certifying your attendance and credit verification will be emailed to you upon completion of the online evaluation survey.
Early Bird Discount
|Other Healthcare Professional
Fellow, Resident, Medical Student
Industry (Not Exhibiting)
Registrants may be asked to furnish documentation confirming their employment status in order to be eligible for the reduced/complimentary rate. If it is determined that a registrant does not meet the eligibility criteria, the registrant will be required to pay the necessary tuition fee.
Space is limited and registration will be accepted on a first-come, first served basis. Once the allotment for each registration category has been reached, a waiting list will be established.
Registration fee includes continental breakfast, refreshment break, lunch, continuing education credits and course materials. Registration can only be accepted through our secure, on-line website through October 11, 2017. Payment may be made with MasterCard or Visa. American Express is not accepted.
PLEASE NOTE: Online registration will close on October 11, 2017 or earlier if seating capacity is reached. Onsite registration will be accommodated on a space-available basis.
Registration: Contact CCOE at 973-972-4267/855-482-1843 or email@example.com
Course Information: Contact Megan Zenuch by phone at 732-937-8748
Once registered, you will receive a confirmation letter and additional information to assist you with your plans to participate in the activity.
A full refund, less a $25 cancellation fee, will be granted if notice is received up to the date of the program. Refunds cannot be given for “no shows” or cancellations received once the program has started. Cancellations must be done online through the registration portal.
HOW TO CANCEL REGISTRATION:
Click here to go to the registration portal. Click "Log in" and enter your user name (email address) and password. Select "Current Schedule" on the top menu, and select “Cancel Registration.”
Rutgers Biomedical and Health Sciences and RWJ Barnabas Health reserve the right to modify the activity content, faculty, and activities and reserve the right to cancel this activity if necessary. If the program is cancelled, liability is limited to the registration fee.